
Replay: Could Ozempic save you from a heart attack?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Anti-obesity jabs like Ozempic could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug.
Researchers found after three years of treatment participants had a 20% lower risk of obesity and its associated health impacts, which currently cost the NHS more than £6bn each year.
On the Sky News Daily, Niall Paterson speaks to Sky's science and medical correspondent Thomas Moore about the implications of reducing heart disease cases for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug actually works.
No reviews yet